Search results
Results from the WOW.Com Content Network
Nasal cavity or paranasal sinus cancer is often discovered when a person is being treated for a seemingly benign, inflammatory disease of the sinuses, such as sinusitis. [4] The signs and symptoms of later stage cancer are generally caused by the spread of malignant cells into the neighbouring structures of the paranasal sinus and nasal cavity. [5]
Sinonasal undifferentiated carcinoma is a rare and aggressive type of cancer originating in the epithelial layer of the nasal cavity or paranasal sinuses. It was first diagnosed in 1987. The aggressive nature of the cancer coupled with the advanced stage of disease upon presentation lead to a poor survival rate.
Head and neck cancer is a general term encompassing multiple cancers that can develop in the head and neck region. These include cancers of the mouth, tongue, gums and lips (oral cancer), voice box (), throat (nasopharyngeal, oropharyngeal, [1] hypopharyngeal), salivary glands, nose and sinuses.
When Christine Spadafor started to experience frightening symptoms, doctors dismissed her concerns. She was finally diagnosed with an egg-size brain tumor. Woman's symptoms were dismissed as sinus ...
Doctors discovered he had a rare cancer in his sinuses and mouth that required several treatments. Man, 27, had what doctors thought were recurring sinus infections — it was a rare cancer Skip ...
On Friday, the China National Medical Products Administration approved GSK plc (NYSE:GSK) Nucala (mepolizumab) as an add-on therapy with intranasal corticosteroids for adult patients with chronic ...
The first line of treatment for nasal polyps is topical steroids. [12] Steroids decrease the inflammation of the sinus mucosa to decrease the size of the polyps and improve symptoms. [12] Topical preparations are preferred in the form of a nasal spray but are often ineffective for people with many polyps.
Treatment of people aged twelve years of age and older with solid tumors that: have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion, are locally advanced or metastatic or where surgical resection is likely to result in severe morbidity, and have progressed following treatment or have no satisfactory alternative therapy [2]